Clinical Trials on Paraganglioma in Spain
Total 5 results
-
Advanced Accelerator ApplicationsActive, not recruitingPheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine TumorsUnited States, Spain, France, Poland, United Kingdom
-
Grupo Espanol de Tumores NeuroendocrinosRoche Pharma AG; IpsenActive, not recruitingAdenocarcinoma | Neuroendocrine Tumor | Pheochromocytoma | Paraganglioma | Anaplastic Thyroid CancerSpain
-
EnteromeActive, not recruitingPheochromocytoma | Paraganglioma | Adrenocortical CarcinomaUnited States, France, Spain, Denmark, Sweden, Germany, Italy, Netherlands
-
Merck Sharp & Dohme LLCRecruitingVon Hippel-Lindau Disease | Pancreatic Neuroendocrine Tumor | Pheochromocytoma/Paraganglioma | Advanced Gastrointestinal Stromal Tumor | HIF-2α Mutated CancersCanada, United States, Denmark, France, Germany, Hungary, Italy, Russian Federation, Spain, Sweden, Turkey, Israel, United Kingdom, Netherlands, Australia, China, Singapore, Japan
-
European Organisation for Research and Treatment...NCIC Clinical Trials GroupCompletedSarcoma | Kidney Cancer | Ovarian Cancer | Endometrial Cancer | PheochromocytomaFrance, Canada, Switzerland, Denmark, Belgium, Netherlands, United Kingdom, Germany, Italy, Slovakia, Spain, Portugal, Austria